limestone has been researched along with osteoprotegerin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiba, T; Kabaya, T; Kawashima, A; Nihei, H; Nitta, K; Uchida, K; Yumura, W | 1 |
Adamo, EB; Altavilla, D; Atteritano, M; Bitto, A; Burnett, BP; Cancellieri, F; Cannata, ML; Corrado, F; D'Anna, R; Di Stefano, V; Frisina, A; Frisina, N; Levy, RM; Lubrano, C; Marini, H; Marini, R; Mazzaferro, S; Minutoli, L; Polito, F; Squadrito, F | 1 |
Bae, YJ; Kim, MH | 1 |
Adamo, EB; Altavilla, D; Bitto, A; Burnett, BP; Irrera, N; Levy, RM; Marini, H; Minutoli, L; Polito, F; Squadrito, F | 1 |
1 trial(s) available for limestone and osteoprotegerin
Article | Year |
---|---|
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study.
Topics: Calcium Carbonate; Cardiovascular Diseases; Cholecalciferol; Female; Follow-Up Studies; Genistein; Homocysteine; Humans; Insulin Resistance; Lipids; Middle Aged; Osteoprotegerin; Postmenopause; Research Design; Risk Factors | 2010 |
3 other study(ies) available for limestone and osteoprotegerin
Article | Year |
---|---|
The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.
Topics: Aortic Diseases; Arteriosclerosis; C-Reactive Protein; Calcinosis; Calcium; Calcium Carbonate; Disease Progression; Female; Glycoproteins; Humans; Kidney Failure, Chronic; Lipids; Longitudinal Studies; Male; Middle Aged; Osteoprotegerin; Parathyroid Hormone; Phosphorus; Prospective Studies; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Renal Dialysis; Risk Factors | 2003 |
Calcium and Magnesium Supplementation Improves Serum OPG/RANKL in Calcium-Deficient Ovariectomized Rats.
Topics: Animals; Bone Density; Calcium; Calcium Carbonate; Calcium, Dietary; Deficiency Diseases; Drug Synergism; Female; Magnesium Oxide; Osteoprotegerin; Ovariectomy; RANK Ligand; Rats; Rats, Sprague-Dawley | 2010 |
Genistein aglycone effect on bone loss is not enhanced by supplemental calcium and vitamin D3: a dose ranging experimental study.
Topics: Alkaline Phosphatase; Animals; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium Carbonate; Cholecalciferol; Compressive Strength; Disease Models, Animal; Drug Therapy, Combination; Female; Femur; Genistein; Osteoprotegerin; Ovariectomy; Plant Extracts; Random Allocation; RANK Ligand; Rats; Rats, Sprague-Dawley; Sophora; Uterus | 2011 |